Archangels - Making The Future

Investment Criteria

The criteria listed below reflect basic guidelines that will be followed in assessing a potential investment. The list is not exhaustive and certain of the criteria may be waived in special circumstances.

  • The company must be based in Scotland, preferably the Central Belt.
  • The business must have high growth potential with international sales potential.
  • The syndicate invests equity only but will assist with the raising of debt as part of a package where appropriate.
  • The investment should be in a sector which qualifies under the Enterprise Investment Scheme.
  • Archangels do not generally invest in retail, leisure, hotels, restaurants or property.
  • The proposal may cover a range from 'proof of concept' through expansion capital and can include start-up, early stage or MBOs.
  • The preferred level of investment is £250-500k but can cover a range from £50k to £2m.

 

 

Latest News

Touch Bionics unveils the new i-LIMB Pulse

05 May 2010
Touch Bionics today announced the launch of the i-LIMB Pulse, an all-new version of the revolutionary i-LIMB Hand, the wordl's first commercially available bionic hand. The i-LIMB Pulse is a significant advance for the i-LIMB product line, with a host of enhancements, including pulsing grip strength, software-enabled grip patterns and robust aluminium features for improved strength.

Touch Bionics wins prestigious Queen's Award for innovation

21 Apr 2010
Touch Bionics, developer of advanced upper-limb bionic technologies, today announced it is a winner of the prestigious Queen's Awards for Enterprise with an award in the Innovation category for 2010. The Queen's Awards for Enterprise are the UK's most prestigious awards for business performance.

Bloxx Delivers Web Filtering Excellence at Wellingborough School

21 Apr 2010
School has immediate access to safe internet surfing with Bloxx Web Filtering. Bloxx today announced that Wellingborough School is providing safe Internet access for around 900 users and achieving superior anonymous proxy detection by using Bloxx's real time Web filtering, powered by its patented Tru-View Technology.

Bloxx helps Yorkshire Building Society keep staff safe online

15 Apr 2010
Bloxx the innovator in Web content filtering, announced on 15th April that Yorkshire Building Society is using Bloxx Web filtering to monitor and report on the Web browsing activity of over 2,000 staff, delivering superior protection from imappropriate or productivity impacting content and minimising network security risks.

New "Penicillin" for the 21st Century

01 Apr 2010
Today MGB Biopharma Limited, a late preclinical stage biopharmaceutical company, has commenced operations in Glasgow, UK to develop and commercialise a new class of antibacterial product: DNA Minor Groove Binders.